Jean-philippe Annereau - Publications

Segmentation of renal tubules and automatic biomarker quantification in ciliopathy preclinical models.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 03, 2025

Prostaglandin Analogs and Eupatilin as Treatments for Nephronophthisis.

Journal: Kidney international reports

Published: January 21, 2025

Ligand-based machine learning models to classify active compounds for prostaglandin EP2 receptor.

Journal: Scientific reports

Published: December 31, 2024

Repurposing small molecules for nephronophthisis and related renal ciliopathies.

Journal: Kidney international

Published: December 20, 2022

A genotype-to-phenotype approach suggests under-reporting of single nucleotide variants in nephrocystin-1 (NPHP1) related disease (UK 100,000 Genomes Project).

Journal: Scientific reports

Published: August 26, 2022

Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 28, 2022

Patient-Patient Similarity-Based Screening of a Clinical Data Warehouse to Support Ciliopathy Diagnosis.

Journal: Frontiers in pharmacology

Published: September 30, 2021

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.

Journal: Cancer letters

Published: June 09, 2015

Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs.

Journal: Bioorganic & medicinal chemistry letters

Published: September 29, 2014

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.

Journal: Journal of dermatological science

Published: May 24, 2012